RecruitingPhase 4

Evaluation of Clinical Impact of the Type of Cardioplegia Used in the Patient Undergoing Major Cardiac Surgery.

Spain600 participantsStarted 2024-12-01

Plain-language summary

Phase IV clinical trial of a single-blind, prospective and longitudinal randomized intervention comparing patients undergoing major cardiac surgery with extracorporeal circulation who are administered Custodiol crystalloid cardioplegia versus Buckberg blood cardioplegia.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Pregnancy.
✕. Aortic arch procedures.
✕. Procedures in which hypothermia \<28ºC is expected during the intervention.
✕. Minimally invasive procedures "Port Access".
✕. Active endocarditis.
✕. Emerging procedures.
✕. Isolated aortic valve replacements.
✕. Decision of the main surgeon not to participate in the study due to other clinical criteria.

What they're measuring

Comparison of the composite event

Timeframe: 90 days after the intervention

Trial details

NCT IDNCT06530641

SponsorLourdes Montero Cruces

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-11

Contact for this trial

Lourdes Montero Cruces

913303000 lourdes.montero@salud.madrid.org

View on ClinicalTrials.gov More Cardiac Surgery trials